Cetera Investment Advisers
CL icon

Cetera Investment Advisers’s Colgate-Palmolive CL Stock Holding History

Cetera Investment Advisers’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33M Buy
387,355
+82,255
+27% +$7.33M 0.04% 498
2025
Q4 		$24.1M Buy
305,100
+103,300
+51% +$8.1M 0.03% 587
2025
Q3 		$16.1M Buy
201,800
+46,391
+30% +$3.96M 0.02% 728
2025
Q2 		$14.1M Sell
155,409
-853
-0.5% -$77.9K 0.02% 655
2025
Q1 		$14.6M Buy
156,262
+20,339
+15% +$1.82M 0.03% 582
2024
Q4 		$12.4M Sell
135,923
-20,130
-13% -$1.92M 0.03% 624
2024
Q3 		$16.2M Buy
156,053
+9,039
+6% +$921K 0.04% 491
2024
Q2 		$14.3M Sell
147,014
-2,166
-1% -$200K 0.03% 513
2024
Q1 		$13.4M Buy
149,180
+107,041
+254% +$9.07M 0.03% 545
2023
Q4 		$3.36M Sell
42,139
-4,529
-10% -$341K 0.03% 588
2023
Q3 		$3.32M Sell
46,668
-8,596
-16% -$643K 0.03% 556
2023
Q2 		$4.26M Buy
55,264
+432
+0.8% +$33.4K 0.04% 461
2023
Q1 		$4.12M Sell
54,832
-2,908
-5% -$216K 0.04% 458
2022
Q4 		$4.55M Buy
57,740
+17,438
+43% +$1.31M 0.04% 414
2022
Q3 		$2.83M Sell
40,302
-7,786
-16% -$611K 0.06% 351
2022
Q2 		$3.85M Sell
48,088
-906
-2% -$70.8K 0.06% 319
2022
Q1 		$3.71M Sell
48,994
-515
-1% -$40.8K 0.05% 356
2021
Q4 		$4.22M Sell
49,509
-1,107
-2% -$86.4K 0.06% 328
2021
Q3 		$3.83M Buy
50,616
+53
+0.1% +$4.21K 0.06% 330
2021
Q2 		$4.11M Buy
50,563
+7,274
+17% +$595K 0.07% 310
2021
Q1 		$3.41M Sell
43,289
-1,888
-4% -$148K 0.07% 303
2020
Q4 		$3.86M Buy
45,177
+31,025
+219% +$2.57M 0.08% 279
2020
Q3 		$1.09M Buy
14,152
+3,711
+36% +$283K 0.09% 250
2020
Q2 		$765K Buy
10,441
+7,287
+231% +$518K 0.07% 280
2020
Q1 		$209K Sell
3,154
-226
-7% -$15.9K 0.03% 484
2019
Q4 		$235K Sell
3,380
-306
-8% -$20.9K 0.02% 510
2019
Q3 		$271K Sell
3,686
-108
-3% -$7.83K 0.03% 427
2019
Q2 		$272K Buy
3,794
+252
+7% +$17.9K 0.04% 411
2019
Q1 		$243K Sell
3,542
-200
-5% -$12.9K 0.03% 410
2018
Q4 		$224K Sell
3,742
-357
-9% -$22.3K 0.04% 401
2018
Q3 		$272K Buy
+4,099
New +$273K 0.04% 388
2017
Q3 		– Sell
-2,730
Closed -$202K – 397
2017
Q2 		$202K Sell
2,730
-24
-0.9% -$1.78K 0.05% 361
2017
Q1 		$203K Buy
+2,754
New +$193K 0.06% 335
2016
Q3 		– Sell
-6,337
Closed -$466K – 287
2016
Q2 		$466K Buy
6,337
+162
+3% +$11.5K 0.18% 146
2016
Q1 		$434K Buy
6,175
+268
+5% +$17.8K 0.19% 145
2015
Q4 		$393K Buy
+5,907
New +$393K 0.18% 152

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cetera Investment Advisers's CL Position: Q1 2026 in Review

Cetera Investment Advisers increased its Colgate-Palmolive (CL) stake by 27% in Q1 2026, buying an estimated $7.33M and bringing the position to 387,355 shares worth $33M. The position accounts for 0.04% of the portfolio, ranked #498.

Cetera Investment Advisers first reported a position in CL in Q4 2015 and has held it in 36 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Cetera Investment Advisers held 387,355 shares of Colgate-Palmolive worth $33M as of Q1 2026.
  • Cetera Investment Advisers bought 82,255 Colgate-Palmolive shares in Q1 2026, an estimated $7.33M.
  • Colgate-Palmolive made up 0.04% of Cetera Investment Advisers's portfolio in Q1 2026, its #498 holding.
  • Cetera Investment Advisers first reported a position in Colgate-Palmolive in Q4 2015 and has held it in 36 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.